- Home
- KRKR vs PULM Comparison
KRKR vs PULM Comparison
Compare KRKR & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRKR | PULM |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 6.1M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KRKR | PULM |
|---|---|---|
| Price | $2.80 | $1.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.3K | ★ 24.6K |
| Earning Date | 03-17-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,910,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5069.93 |
| 52 Week Low | $2.50 | $1.16 |
| 52 Week High | $21.36 | $5.80 |
Technical Indicators
Market Signals| Indicator | KRKR | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 55.11 |
| Support Level | $2.51 | $1.59 |
| Resistance Level | $2.89 | $1.88 |
| Average True Range (ATR) | 0.22 | 0.11 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 28.67 | 44.27 |
Price Performance
Historical ComparisonAbout KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in the PRC.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).